Written question asked by Kelvin Hopkins (Labour) on Thursday, 17 November 2016, in the House of Commons. It was due for an answer on Monday, 21 November 2016. It was answered by Baroness Blackwood of North Oxford (Conservative) on Wednesday, 23 November 2016 on behalf of the Department of Health.
ME/CFS: Medical Treatments
- Question
-
To ask the Secretary of State for Health, with reference to the PACE trial, Pacing, graded Activity and Cognitive Behaviour Therapy, if he will ask NICE and the NHS to revise their approach to treating myalgic encephalomyelitis to removing references to Cognitive Behaviour Therapy and Graded Exercise Therapy.
- Answer
-
The National Institute for Health and Care Excellence (NICE) is an independent body and is responsible for ensuring that its guidance remains up to date. NICE has advised that it has brought forward the next review date for its guidance on the diagnosis and management of chronic fatigue syndrome/myalgic encephalomyelitis from 2019 to 2017 to coincide with the expected publication of relevant new evidence.
NICE’s aim is to make a decision on whether an update of the guideline is required by the end of 2017.
Secondary information
- Type
- Written question
- Reference
- 53645
- Session
- 2016-17
- Subjects
- ME/CFS Medical treatments
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-05-06 14:05:50 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/53645
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/53645
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2016-17/53645